HomeIBT-B • STO
add
Infant Bacterial Therapeutics AB
Previous close
kr 56.20
Day range
kr 54.80 - kr 56.90
Year range
kr 21.70 - kr 135.00
Market cap
736.83M SEK
Avg Volume
29.68K
P/E ratio
-
Dividend yield
-
Primary exchange
STO
Market news
Financials
Income Statement
Revenue
Net income
| (SEK) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 17.50M | -41.30% |
Net income | -16.74M | 39.82% |
Net profit margin | — | — |
Earnings per share | — | — |
EBITDA | — | — |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (SEK) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 191.76M | -38.07% |
Total assets | 207.92M | -40.40% |
Total liabilities | 54.39M | -23.97% |
Total equity | 153.52M | — |
Shares outstanding | 13.47M | — |
Price to book | 4.93 | — |
Return on assets | -19.55% | — |
Return on capital | -27.02% | — |
Cash Flow
Net change in cash
| (SEK) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -16.74M | 39.82% |
Cash from operations | -27.98M | -12.96% |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | -31.63M | -62.66% |
Free cash flow | -25.82M | -151.87% |
About
Founded
2011
Website
Employees
8
